Decrease in serum IL-32 level in patients with atopic dermatitis after cyclosporine treatment.

Kitayama, N; Otsuka, A; Nonomura, Y; Nakashima, C; Honda, T; Kabashima, K

Kitayama, N; Otsuka, A; Nonomura, Y; Nakashima, C; Honda, T; Kabashima, K.

Affiliation

Kitayama N; Department of Dermatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawara, Kyoto, 606-8507, Japan.
Otsuka A; Department of Dermatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawara, Kyoto, 606-8507, Japan.
Nonomura Y; Department of Dermatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawara, Kyoto, 606-8507, Japan.
Nakashima C; Department of Dermatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawara, Kyoto, 606-8507, Japan.
Honda T; Department of Dermatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawara, Kyoto, 606-8507, Japan.
Kabashima K; Department of Dermatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawara, Kyoto, 606-8507, Japan.

J Eur Acad Dermatol Venereol ; 31(10): e449-e450, 2017 Oct.

Article in En | MEDLINE | ID: mdl-28403511

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukins / Cyclosporine / Dermatitis, Atopic / Dermatologic Agents Limits: Adolescent / Adult / Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2017 Document type: Article Affiliation country:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google